Prognostic relevance of heart rate at rest for survival and the quality of life in patients with dilated cardiomyopathy

Clinical Research in Cardiology

Volumn 101, Issue 9, 2012, Pages 701-707

  Fujita, Buntaro ^a   Franz, Marcus ^a   Goebel, Bjoern ^a   Fritzenwanger, Michael ^a   Figulla, Hans R ^a   Kuethe, Friedhelm ^a   Ferrari, Markus ^a   Jung, Christian ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

DCM; Follow up; Heart failure; Heart rate; Minnesota; Quality of life

Indexed keywords

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; FEMALE; FOLLOW UP; HEART MUSCLE BIOPSY; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SURVIVAL RATE;

ADULT; CARDIOMYOPATHY, DILATED; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84866088426     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-012-0447-z     Document Type: Article

References (37)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2010) Executive summary: heart disease and stroke statistics2010 update. Circulation 121(7):948-954. doi: 10.1161/circulationaha.109.192666
2. Krum H, Teerlink JR (2011) Medical therapy for chronic heart failure. The Lancet 378(9792):713-721. doi: 10.1016/S0140-6736(11)61038-6
3. Ferrari R, Ceconi C (2011) Selective and specific if inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease. Expert Rev Cardiovasc Ther 9(8):959-973. doi: 10.1586/erc.11.99
4. Reil J-C, Custodis F, Swedberg K, Komajda M, Borer J, Ford I, Tavazzi L, Laufs U, Böhm M (2011) Heart rate reduction in cardiovascular disease and therapy. Clin Res Cardiol 100(1):11-19. doi: 10.1007/s00392-010-0207-x
5. Fox K, Ford I, Steg PG, Tendera M, Ferrari R (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372(9641):807-816. doi: 10.1016/S0140-6736(08)61170-8
6. Tardif J-C, Ponikowski P, Kahan T (2009) Efficacy of the if current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 30(5):540-548. doi: 10.1093/eurheartj/ehn571
7. Werdan K, Ebelt H, Nuding S, Höpfner F, Hack G, Müller-Werdan U (2012) Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study. Clin Res Cardiol, pp 1-9. doi: 10.1007/s00392-011-0402-4
8. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R (2009) Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J 30(19):2337-2345. doi: 10.1093/eurheartj/ehp358
9. Koester R, Kaehler J, Meinertz T (2011) Ivabradine for the treatment of stable angina pectoris in octogenarians. Clin Res Cardiol 100(2):121-128. doi: 10.1007/s00392-010-0220-0
10. Kolloch R, Legler UF, Champion A, Cooper-DeHoff RM, Handberg E, Zhou Q, Pepine CJ (2008) Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J 29(10):1327-1334. doi: 10.1093/eurheartj/ehn123 (Pubitemid 351768127)
11. Rambihar S, Gao P, Teo K, Bohm M, Yusuf S, Lonn E, On Behalf of the ONTARGET/TRANSCEND Investigators (2010) Abstract 12667: heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular diseasean analysis of ONTARGET/TRANSCEND. Circulation 122(21 Supplement):A12667
12. Ekman I, Chassany O, Komajda M, Böhm M, Borer JS, Ford I, Tavazzi L, Swedberg K (2011) Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. Eur Heart J 32(19):2395-2404. doi: 10.1093/eurheartj/ehr343
13. Mommersteeg PMC, Denollet J, Spertus JA, Pedersen SS (2009) Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J 157(2):208-218. doi: 10.1016/j.ahj.2008.09.020
14. Morgan K, McGee H, Shelley E (2007) Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review. J Cardiovasc Risk 14(5):589-607. doi: 10.1097/HJR.0b013e32828622c3 (Pubitemid 47556395)
15. O'Connell JB, Costanzo-Nordin MR, Subramanian R, Robinson J (1986) Dilated cardiomyopathy: emerging role of endomyocardial biopsy. Curr Probl Cardiol 11(8):448-507. doi: 10.1016/0146-2806(86)90029-0
16. Olsen EG (1979) The pathology of cardiomyopathies. A critical analysis. Am Heart J 98(3):385-392. doi: 10.1016/0002-8703(79)90052-8 (Pubitemid 10217719)
17. Luk A, Ahn E, Soor GS, Butany J (2009) Dilated cardiomyopathy: a review. J Clin Pathol 62(3):219-225. doi: 10.1136/jcp.2008.060731
18. Yonesaka S, Becker AE (1987) Dilated cardiomyopathy: diagnostic accuracy of endomyocardial biopsy. Br Heart J 58(2):156-161. doi: 10.1136/hrt.58.2.156 (Pubitemid 17124956)
19. Garin O, Ferrer M, Pont À, Rué M, Kotzeva A, Wiklund I, Van Ganse E, Alonso J (2009) Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res 18(1):71-85. doi: 10.1007/s11136-008-9416-4
20. Bennett SJ, Oldridge NB, Eckert GJ, Embree JL, Browning S, Hou N, Deer M, Murray MD (2002) Discriminant properties of commonly used quality of life measures in heart failure. Qual Life Res 11(4):349-359. doi: 10.1023/A:1015547713061 (Pubitemid 34596857)
21. Quittan M, Wiesinger GF, Crevenna R, Nuhr MJ, Posch M, Hülsmann M, Müller D, Pacher R, Fialka-Moser V (2001) Cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients. J Rehabil Med 33(4):182-186. doi: 10.1080/16501970121386 (Pubitemid 32700480)
22. Ceconi C, Guardigli G, Rizzo P, Francolini G, Ferrari R (2011) The heart rate story. Eur Heart J Suppl 13(suppl C):C4-C13. doi: 10.1093/eurheartj/sur014
23. Morrissey RP, Czer L, Shah PK (2011) Chronic heart failure: current evidence, challenges to therapy, and future directions. Am J Cardiovasc Drugs 11(3):153-171. doi: 10.2165/11592090-000000000-00000
24. Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U (2008) Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 117(18):2377-2387. doi: 10.1161/circulationaha. 107.746537 (Pubitemid 351653554)
25. Giannoglou GD, Chatzizisis YS, Zamboulis C, Parcharidis GE, Mikhailidis DP, Louridas GE (2008) Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 126(3):302-312. doi: 10.1016/j.ijcard.2007.08.077
26. Lang CC, Gupta S, Kalra P, Keavney B, Menown I, Morley C, Padmanabhan S (2010) Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: clinical evidence and pathophysiological mechanisms. Atherosclerosis 212(1):1-8. doi: 10.1016/j.atherosclerosis.2010.01.029
27. Hasenfuss G, Holumbarsch C, Hermann H-P, Astheimer K, Pleske B, Just H (1994) Influence of the forcefrequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 15(2):164-170 (Pubitemid 24110691)
28. Clements IP, Miller WL, Olson LJ (1999) Resting heart rate and cardiac function in dilated cardiomyopathy. Int J Cardiol 72(1):27-37. doi: 10.1016/S0167-5273(99)00139-4
29. Rayan M, Tawfik M, Alabd A, Gamal A (2011) Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy? Anadolu Kardiyol Derg 11(5):402-406. doi: 10.5152/akd.2011.110
30. Gillman MW, Kannel WB, Belanger A, Dagostino RB (1993) Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 125(4):1148-1154. doi: 10.1016/0002-8703(93)90128-V (Pubitemid 23117352)
31. Thomas F, Rudnichi A, Bacri A-M, Bean K, Guize L, Benetos A (2001) Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 37(5):1256-1261. doi: 10.1161/01.HYP.37.5.1256 (Pubitemid 34163578)
32. Shah MR, Hasselblad V, Stinnett SS, Kramer JM, Grossman S, Gheorghiade M, Adams KF, Swedberg K, Califf RM, O'Connor CM (2002) Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure. Eur J Heart Fail 4(3):297-304. doi: 10.1016/S1388-9842(01)00202- 1 (Pubitemid 35190354)
33. Hoekstra T, Lesman-Leegte I, van Veldhuisen DJ, Sanderman R, Jaarsma T (2011) Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail 13(9):1013-1018. doi: 10.1093/eurjhf/hfr072
34. Rogers WJ, Johnstone DE, Yusuf S, Weiner DH, Gallagher P, Bittner VA, Ahn S, Schron E, Shumaker SA, Sheffield LT (1994) Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. J Am Coll Cardiol 23(2):393-400. doi: 10.1016/0735-1097(94)90426-X (Pubitemid 24049371)
35. Evangelista LS, Moser DK, Westlake C, Hamilton MA, Fonarow GC, Dracup K (2006) Impact of obesity on quality of life and depression in patients with heart failure. Eur J Heart Fail 8(7):750-755. doi: 10.1016/j.ejheart.2006.02.004 (Pubitemid 44740403)
36. Fujita B, Lauten A, Goebel B, Franz M, Fritzenwanger M, Ferrari M, Figulla H, Kuethe F, Jung C (2011) Impact of diabetes mellitus on quality of life in patients with congestive heart failure. Qual Life Res. doi: 10.1007/s11136-011-0039-9
37. Hallas CN, Wray J, Andreou P, Banner NR (2011) Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart Lung J Acute Crit Care 40(2):111-121. doi: 10.1016/j.hrtlng.2009. 12.008